Murray’s Clinical Innovations has been purchased by Laborie Medical Technologies, a urology and gastrointestinal diagnostic equipment company based in Burlington, Massachusetts. The sales price was announced as $525 million.
Clinical Innovations is a global provider of medical devices for the labor and delivery and neonatal intensive care unit specialties.
“This is a promising deal that will add scale to Clinical Innovations,” said Ken Reali, president and CEO of Clinical Innovations. “We share a similar vision for the continued growth of Clinical Innovations. The combination of Clinical Innovations and Laborie will have a positive impact for mothers, babies and healthcare professionals.”
“The acquisition of Clinical Innovations supports the successful evolution of our business and advances Laborie’s strategy to invest in market leading technologies that address high-growth medical specialties, delivering clinical, access and/or economic advantages,” said Michael Frazzette, president and CEO of Laborie. “Clinical Innovations provides Laborie with a strong global presence in the labor and delivery and neonatal intensive care unit specialties and the company’s diversified and differentiated market-leading product portfolio truly makes a difference for clinicians and their patients.”
Clinical Innovations has sales and logistics satellite offices around the United States, Europe, Australia and China. Founded in 1993, the company employs about 250 people.